Skip to main content
. 2020 Aug 26;111(10):3759–3769. doi: 10.1111/cas.14582

FIGURE 2.

FIGURE 2

Kaplan‐Meier curves of the intent‐to‐treat (ITT) population in the tivantinib group (blue line) vs the placebo group (yellow line). A, Progression‐free survival (PFS) based on independent radiological committee. B, Overall survival (OS)